Does LEUPROLIDE Cause Intensive care unit acquired weakness? 6 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Intensive care unit acquired weakness have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.0% of all adverse event reports for LEUPROLIDE.
6
Reports of Intensive care unit acquired weakness with LEUPROLIDE
0.0%
of all LEUPROLIDE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Intensive care unit acquired weakness From LEUPROLIDE?
Of the 6 reports, 6 (100.0%) required hospitalization.
Is Intensive care unit acquired weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Intensive care unit acquired weakness?
METHYLPREDNISOLONE (57)
PROPOFOL (55)
MIDAZOLAM (49)
PREDNISOLONE (47)
PREDNISONE (45)
MYCOPHENOLATE MOFETIL (42)
THIOPENTAL (41)
FENTANYL (40)
LEVETIRACETAM (40)
VANCOMYCIN (37)
Which LEUPROLIDE Alternatives Have Lower Intensive care unit acquired weakness Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM